Deep Track Capital is a healthcare-focused fund, and its 9.9% stake in a SPAC suggests interest in a potential de-SPAC target in the biotech/life sciences space. Monitor for any future conversion to a Schedule 13D or announcements regarding a business combination target.
Price Chart
Executive Summary
Deep Track Capital, a healthcare-focused hedge fund, disclosed a 9.9% passive stake in TCGX Acquisition Corp. II (a SPAC), holding 990,000 Class A ordinary shares via its funds and control person David Kroin. The filing is a standard Schedule 13G indicating no intent to influence or change control, making it a routine passive ownership disclosure for a blank-check company.
Key Financial Metrics
Key Facts
- Deep Track Capital, LP disclosed beneficial ownership of 990,000 Class A ordinary shares of TCGX Acquisition Corp. II, representing 9.9% of shares outstanding.
- The stake is held through Deep Track Biotechnology Master Fund, Ltd. (711,513 shares, 7.12%) and Deep Track Special Opportunities Fund, LP (278,487 shares, 2.78%).
- David Kroin is the control person of Deep Track Capital and is also named as a reporting person.
- The filing is made under Rule 13d-1(c), confirming the securities were not acquired with the purpose of changing or influencing control of the issuer.
- The issuer is a blank-check company (SPAC) with 10,000,000 Class A ordinary shares outstanding as of October 16, 2026.
Financial Impact
Passive stake of 9.9% — no direct financial impact; the stake value is not disclosed in the filing.
Risk Factors
- Passive 13G filing — no commitment to activism or deal support; fund could exit without notice.
- SPACs carry inherent risk of failing to identify a suitable merger target or shareholder redemption pressure.
Documents Analyzed
This report is based on 3 SEC documents filed with EDGAR.
| Document | Accession Number |
|---|---|
| SC 13G Filing (Primary) | 0001172661-26-004681 |
| Document: 0001172661-26-004681-index.html | 0001172661-26-004681 |
| Document: 0001172661-26-004681.txt | 0001172661-26-004681 |
Filters
| Type | Now | ||||
|---|---|---|---|---|---|
Oct 26, 2026 1d ago | SC 13G | $10.27 | awaiting T+20 | — | $10.28 (+0.10%) |
Oct 26, 2026 1d ago | SC 13G | $10.27 | awaiting T+20 | — | $10.28 (+0.10%) |
Oct 23, 2026 4d ago | SC 13G | $10.27 | awaiting T+20 | — | $10.28 (+0.10%) |
Oct 23, 2026 4d ago | SC 13G | $10.27 | awaiting T+20 | — | $10.28 (+0.10%) |
Oct 20, 2026 7d ago | 3 | $10.50 | awaiting T+20 | — | $10.28 (−2.10%) |
Oct 20, 2026 7d ago | 3 | $10.50 | awaiting T+20 | — | $10.28 (−2.10%) |
Oct 19, 2026 8d ago | 8-K | $10.56 | awaiting T+20 | — | $10.28 (−2.65%) |
Oct 16, 2026 11d ago | 424B4 | $10.40 | awaiting T+20 | — | $10.28 (−1.15%) |
Oct 16, 2026 11d ago | EFFECT | $10.86 | awaiting T+20 | — | $10.28 (−5.34%) |
Oct 15, 2026 11d ago | 3 | $10.86 | awaiting T+20 | — | $10.28 (−5.34%) |
US Market Status
Subscribe to SecBot
Get Real-Time SEC Filing Intelligence
Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.
Create a free account Live analysis, Telegram alerts, watchlists and the MCP server for subscribers